Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 76

1.

Fenretinide, Tocilizumab, and Reparixin Provide Multifaceted Disruption of Oral Squamous Cell Carcinoma Stem Cell Properties: Implications for Tertiary Chemoprevention.

Mallery SR, Wang D, Santiago B, Pei P, Bissonnette C, Jayawardena JA, Schwendeman SP, Spinney R, Lang J.

Mol Cancer Ther. 2019 Dec;18(12):2308-2320. doi: 10.1158/1535-7163.MCT-19-0361. Epub 2019 Sep 12.

PMID:
31515297
2.

In vivo controlled release of fenretinide from long-acting release depots for chemoprevention of oral squamous cell carcinoma recurrence.

Nieto K, Pei P, Wang D, Mallery SR, Schwendeman SP.

Int J Pharm. 2018 Mar 1;538(1-2):48-56. doi: 10.1016/j.ijpharm.2017.11.037. Epub 2017 Nov 21.

3.

Benefits of Multifaceted Chemopreventives in the Suppression of the Oral Squamous Cell Carcinoma (OSCC) Tumorigenic Phenotype.

Mallery SR, Wang D, Santiago B, Pei P, Schwendeman SP, Nieto K, Spinney R, Tong M, Koutras G, Han B, Holpuch A, Lang J.

Cancer Prev Res (Phila). 2017 Jan;10(1):76-88. doi: 10.1158/1940-6207.CAPR-16-0180. Epub 2016 Oct 18.

4.

Black raspberries in cancer clinical trials: Past, present and future.

Kresty LA, Mallery SR, Stoner GD.

J Berry Res. 2016;6(2):251-261.

5.

Chronic ulceration of the tongue.

Briody A, Santosh N, Allen CM, Mallery SR, McNamara KK.

J Am Dent Assoc. 2016 Sep;147(9):744-8. doi: 10.1016/j.adaj.2016.05.009. Epub 2016 Jul 15. No abstract available.

PMID:
27426484
6.

Reconstructing jaw defects with MSCs and PLGA-encapsulated growth factors.

Tee BC, Desai KG, Kennedy KS, Sonnichsen B, Kim DG, Fields HW, Mallery SR, Schwendeman SP, Sun Z.

Am J Transl Res. 2016 Jun 15;8(6):2693-704. eCollection 2016.

7.

Fenretinide Perturbs Focal Adhesion Kinase in Premalignant and Malignant Human Oral Keratinocytes. Fenretinide's Chemopreventive Mechanisms Include ECM Interactions.

Han BB, Li S, Tong M, Holpuch AS, Spinney R, Wang D, Border MB, Liu Z, Sarode S, Pei P, Schwendeman SP, Mallery SR.

Cancer Prev Res (Phila). 2015 May;8(5):419-30. doi: 10.1158/1940-6207.CAPR-14-0418. Epub 2015 Feb 24.

8.

Diet and esophageal disease.

Dawsey SM, Fagundes RB, Jacobson BC, Kresty LA, Mallery SR, Paski S, van den Brandt PA.

Ann N Y Acad Sci. 2014 Sep;1325:127-37. doi: 10.1111/nyas.12528.

9.

Topical application of a mucoadhesive freeze-dried black raspberry gel induces clinical and histologic regression and reduces loss of heterozygosity events in premalignant oral intraepithelial lesions: results from a multicentered, placebo-controlled clinical trial.

Mallery SR, Tong M, Shumway BS, Curran AE, Larsen PE, Ness GM, Kennedy KS, Blakey GH, Kushner GM, Vickers AM, Han B, Pei P, Stoner GD.

Clin Cancer Res. 2014 Apr 1;20(7):1910-24. doi: 10.1158/1078-0432.CCR-13-3159. Epub 2014 Jan 31.

10.

Clinical and biochemical studies support smokeless tobacco's carcinogenic potential in the human oral cavity.

Mallery SR, Tong M, Michaels GC, Kiyani AR, Hecht SS.

Cancer Prev Res (Phila). 2014 Jan;7(1):23-32. doi: 10.1158/1940-6207.CAPR-13-0262. Epub 2013 Nov 21.

11.

Scaffold-based delivery of autologous mesenchymal stem cells for mandibular distraction osteogenesis: preliminary studies in a porcine model.

Sun Z, Tee BC, Kennedy KS, Kennedy PM, Kim DG, Mallery SR, Fields HW.

PLoS One. 2013 Sep 5;8(9):e74672. doi: 10.1371/journal.pone.0074672. eCollection 2013.

12.

Inherent phenotypic plasticity facilitates progression of head and neck cancer: endotheliod characteristics enable angiogenesis and invasion.

Tong M, Han BB, Holpuch AS, Pei P, He L, Mallery SR.

Exp Cell Res. 2013 Apr 15;319(7):1028-42. doi: 10.1016/j.yexcr.2013.01.013. Epub 2013 Jan 29.

13.

Pharmacokinetics of protocatechuic acid in mouse and its quantification in human plasma using LC-tandem mass spectrometry.

Chen W, Wang D, Wang LS, Bei D, Wang J, See WA, Mallery SR, Stoner GD, Liu Z.

J Chromatogr B Analyt Technol Biomed Life Sci. 2012 Nov 1;908:39-44. doi: 10.1016/j.jchromb.2012.09.032. Epub 2012 Sep 27.

14.

Evaluation of a mucoadhesive fenretinide patch for local intraoral delivery: a strategy to reintroduce fenretinide for oral cancer chemoprevention.

Holpuch AS, Phelps MP, Desai KG, Chen W, Koutras GM, Han BB, Warner BM, Pei P, Seghi GA, Tong M, Border MB, Fields HW, Stoner GD, Larsen PE, Liu Z, Schwendeman SP, Mallery SR.

Carcinogenesis. 2012 May;33(5):1098-105. doi: 10.1093/carcin/bgs122. Epub 2012 Mar 15.

15.

Mucoadhesive fenretinide patches for site-specific chemoprevention of oral cancer: enhancement of oral mucosal permeation of fenretinide by coincorporation of propylene glycol and menthol.

Wu X, Desai KG, Mallery SR, Holpuch AS, Phelps MP, Schwendeman SP.

Mol Pharm. 2012 Apr 2;9(4):937-45. doi: 10.1021/mp200655k. Epub 2012 Mar 6.

16.

Optimizing therapeutic efficacy of chemopreventive agents: A critical review of delivery strategies in oral cancer chemoprevention clinical trials.

Holpuch AS, Desai KG, Schwendeman SP, Mallery SR.

J Carcinog. 2011;10:23. doi: 10.4103/1477-3163.85185. Epub 2011 Sep 21.

17.

Development and in vitro-in vivo evaluation of fenretinide-loaded oral mucoadhesive patches for site-specific chemoprevention of oral cancer.

Desai KG, Mallery SR, Holpuch AS, Schwendeman SP.

Pharm Res. 2011 Oct;28(10):2599-609. doi: 10.1007/s11095-011-0489-3. Epub 2011 Jun 15.

18.

Effects of human oral mucosal tissue, saliva, and oral microflora on intraoral metabolism and bioactivation of black raspberry anthocyanins.

Mallery SR, Budendorf DE, Larsen MP, Pei P, Tong M, Holpuch AS, Larsen PE, Stoner GD, Fields HW, Chan KK, Ling Y, Liu Z.

Cancer Prev Res (Phila). 2011 Aug;4(8):1209-21. doi: 10.1158/1940-6207.CAPR-11-0040. Epub 2011 May 10.

19.

Nanoparticles for local drug delivery to the oral mucosa: proof of principle studies.

Holpuch AS, Hummel GJ, Tong M, Seghi GA, Pei P, Ma P, Mumper RJ, Mallery SR.

Pharm Res. 2010 Jul;27(7):1224-36. doi: 10.1007/s11095-010-0121-y. Epub 2010 Mar 31.

20.

Formulation and in vitro-in vivo evaluation of black raspberry extract-loaded PLGA/PLA injectable millicylindrical implants for sustained delivery of chemopreventive anthocyanins.

Desai KG, Olsen KF, Mallery SR, Stoner GD, Schwendeman SP.

Pharm Res. 2010 Apr;27(4):628-43. doi: 10.1007/s11095-009-0038-5. Epub 2010 Feb 11.

21.

A rapid and sensitive LC-MS/MS method for quantification of four anthocyanins and its application in a clinical pharmacology study of a bioadhesive black raspberry gel.

Ling Y, Ren C, Mallery SR, Ugalde CM, Pei P, Saradhi UV, Stoner GD, Chan KK, Liu Z.

J Chromatogr B Analyt Technol Biomed Life Sci. 2009 Dec 1;877(31):4027-34. doi: 10.1016/j.jchromb.2009.10.026. Epub 2009 Oct 30.

22.

Distribution of anthocyanins delivered from a bioadhesive black raspberry gel following topical intraoral application in normal healthy volunteers.

Ugalde CM, Liu Z, Ren C, Chan KK, Rodrigo KA, Ling Y, Larsen PE, Chacon GE, Stoner GD, Mumper RJ, Fields HW, Mallery SR.

Pharm Res. 2009 Apr;26(4):977-86. doi: 10.1007/s11095-008-9806-x. Epub 2009 Jan 10.

23.

Frequent alterations of p16INK4a and p14ARF in oral proliferative verrucous leukoplakia.

Kresty LA, Mallery SR, Knobloch TJ, Li J, Lloyd M, Casto BC, Weghorst CM.

Cancer Epidemiol Biomarkers Prev. 2008 Nov;17(11):3179-87. doi: 10.1158/1055-9965.EPI-08-0574.

24.

Human head and neck squamous cell carcinoma cells are both targets and effectors for the angiogenic cytokine, VEGF.

Tong M, Lloyd B, Pei P, Mallery SR.

J Cell Biochem. 2008 Dec 1;105(5):1202-10. doi: 10.1002/jcb.21920.

25.

Topical application of a bioadhesive black raspberry gel modulates gene expression and reduces cyclooxygenase 2 protein in human premalignant oral lesions.

Mallery SR, Zwick JC, Pei P, Tong M, Larsen PE, Shumway BS, Lu B, Fields HW, Mumper RJ, Stoner GD.

Cancer Res. 2008 Jun 15;68(12):4945-57. doi: 10.1158/0008-5472.CAN-08-0568.

26.

Effect of formulation parameters on 2-methoxyestradiol release from injectable cylindrical poly(DL-lactide-co-glycolide) implants.

Desai KG, Mallery SR, Schwendeman SP.

Eur J Pharm Biopharm. 2008 Sep;70(1):187-98. doi: 10.1016/j.ejpb.2008.03.007. Epub 2008 Mar 20.

27.

Effects of a topically applied bioadhesive berry gel on loss of heterozygosity indices in premalignant oral lesions.

Shumway BS, Kresty LA, Larsen PE, Zwick JC, Lu B, Fields HW, Mumper RJ, Stoner GD, Mallery SR.

Clin Cancer Res. 2008 Apr 15;14(8):2421-30. doi: 10.1158/1078-0432.CCR-07-4096.

28.

The effects of reactive species on the tumorigenic phenotype of human head and neck squamous cell carcinoma (HNSCC) cells.

Bradburn JE, Pei P, Kresty LA, Lang JC, Yates AJ, McCormick AP, Mallery SR.

Anticancer Res. 2007 Nov-Dec;27(6B):3819-27.

29.
30.
31.

Rescue of SCID murine ischemic hindlimbs with pH-modified rhbFGF/poly(DL-lactic-co-glycolic acid) implants.

Zhong Y, Zhang L, Ding AG, Shenderova A, Zhu G, Pei P, Chen RR, Mallery SR, Mooney DJ, Schwendeman SP.

J Control Release. 2007 Oct 8;122(3):331-7. Epub 2007 May 23.

PMID:
17706831
32.

Cyclooxygenase-2 directly induces MCF-7 breast tumor cells to develop into exponentially growing, highly angiogenic and regionally invasive human ductal carcinoma xenografts.

Robertson FM, Mallery SR, Bergdall-Costell VK, Cheng M, Pei P, Prosperi JR, Ferrari M.

Anticancer Res. 2007 Mar-Apr;27(2):719-27.

33.

Formulation and in-vitro and in-vivo evaluation of a mucoadhesive gel containing freeze dried black raspberries: implications for oral cancer chemoprevention.

Mallery SR, Stoner GD, Larsen PE, Fields HW, Rodrigo KA, Schwartz SJ, Tian Q, Dai J, Mumper RJ.

Pharm Res. 2007 Apr;24(4):728-37. Epub 2007 Feb 15.

34.

Reduced nonprotein thiols inhibit activation and function of MMP-9: implications for chemoprevention.

Pei P, Horan MP, Hille R, Hemann CF, Schwendeman SP, Mallery SR.

Free Radic Biol Med. 2006 Oct 15;41(8):1315-24. Epub 2006 Jul 15.

35.

Activation of Akt and mTOR in CD34+/K15+ keratinocyte stem cells and skin tumors during multi-stage mouse skin carcinogenesis.

Affara NI, Trempus CS, Schanbacher BL, Pei P, Mallery SR, Bauer JA, Robertson FM.

Anticancer Res. 2006 Jul-Aug;26(4B):2805-20.

36.

Kinetic modeling of nitric-oxide-associated reaction network.

Hu TM, Hayton WL, Mallery SR.

Pharm Res. 2006 Aug;23(8):1702-11.

PMID:
16850266
37.
38.

Expression of the serine protease DESC1 correlates directly with normal keratinocyte differentiation and inversely with head and neck squamous cell carcinoma progression.

Sedghizadeh PP, Mallery SR, Thompson SJ, Kresty L, Beck FM, Parkinson EK, Biancamano J, Lang JC.

Head Neck. 2006 May;28(5):432-40.

PMID:
16320362
39.

Sanguinarine activates polycyclic aromatic hydrocarbon associated metabolic pathways in human oral keratinocytes and tissues.

Karp JM, Rodrigo KA, Pei P, Pavlick MD, Andersen JD, McTigue DJ, Fields HW, Mallery SR.

Toxicol Lett. 2005 Jul 28;158(1):50-60. Epub 2005 Apr 1.

PMID:
15993743
40.

Presentation of an epithelioid cell histiocytoma on the ventral tongue.

Rawal YB, Kalmar JR, Shumway B, Mallery SR.

Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2005 Jul;100(1):75-83.

PMID:
15953920
41.

Immunohistochemical assessment of Viadent-associated leukoplakia.

Anderson KM, Stoner GD, Fields HW, Chacon GE, Dohar AL, Gregg BR, Mallery SR.

Oral Oncol. 2005 Feb;41(2):200-7.

PMID:
15695122
42.

Comparison of phenethyl and 6-phenylhexyl isothiocyanate-induced toxicity in rat esophageal cell lines with and without glutathione depletion.

Hudson TS, Stoner GD, Morse MA, Young H, Mallery SR.

Toxicol Lett. 2005 Mar 15;155(3):427-36.

PMID:
15649627
43.

Activated Akt-1 in specific cell populations during multi-stage skin carcinogenesis.

Affara NI, Schanbacher BL, Mihm MJ, Cook AC, Pei P, Mallery SR, Trempus CS, Bauer JA, Robertson FM.

Anticancer Res. 2004 Sep-Oct;24(5A):2773-81.

44.

MALT Lymphoma in Children: Case Report and Review of the Literature.

Mo JQ, Dimashkieh H, Mallery SR, Swerdlow SH, Bove KE.

Pediatr Dev Pathol. 2004 Jul-Aug;7(4):407-13.

PMID:
15455481
45.

AIDS-associated malignancies.

Shah MH, Porcu P, Mallery SR, Caligiuri MA.

Cancer Chemother Biol Response Modif. 2003;21:717-46. Review. No abstract available.

PMID:
15338771
46.

Invasive and angiogenic phenotype of MCF-7 human breast tumor cells expressing human cyclooxygenase-2.

Prosperi JR, Mallery SR, Kigerl KA, Erfurt AA, Robertson FM.

Prostaglandins Other Lipid Mediat. 2004 Apr;73(3-4):249-64.

PMID:
15290792
47.

Implications for oxidative and nitrative stress in the pathogenesis of AIDS-related Kaposi's sarcoma.

Mallery SR, Pei P, Landwehr DJ, Clark CM, Bradburn JE, Ness GM, Robertson FM.

Carcinogenesis. 2004 Apr;25(4):597-603. Epub 2003 Dec 4.

48.

Endostatin inhibits migration and invasion of head and neck squamous cell carcinoma cells.

Wilson RF, Morse MA, Pei P, Renner RJ, Schuller DE, Robertson FM, Mallery SR.

Anticancer Res. 2003 Mar-Apr;23(2B):1289-95.

PMID:
12820385
49.

AIDS-associated malignancies.

Shah MH, Porcu P, Mallery SR, Caligiuri MA.

Cancer Chemother Biol Response Modif. 2002;20:633-64. Review. No abstract available.

PMID:
12703228
50.

AIDS-related Kaposi's sarcoma cells rapidly internalize endostatin, which co-localizes to tropomysin microfilaments and inhibits cytokine-mediated migration and invasion.

Mallery SR, Morse MA, Wilson RF, Pei P, Ness GM, Bradburn JE, Renner RJ, Schuller DE, Robertson FM.

J Cell Biochem. 2003 May 1;89(1):133-43.

PMID:
12682914

Supplemental Content

Loading ...
Support Center